George Tidmarsh, the top drug regulator at the US Food and Drug Administration (FDA), has left the agency following claims in ...

The Wall Street Journal's conservative editorial board bashed the "dysfunction" that appears to be hampering the Food and ...

On this week’s episode of "The Readout LOUD," melodrama at the top of the FDA and the latest on the Pfizer-Novo Nordisk ...

Federal budget cuts pose a threat to progress that has improved lung cancer survival, according to the American Lung ...

The head of the FDA's drug division resigned while under internal investigation, saying he was pushed out after raising concerns.

The search continues for a new leader for the FDA’s Center for Drug Evaluation and Research after George Tidmarsh resigned on ...

Reports suggest that, internally, the Food and Drug Administration is facing a crisis of confidence.

This week, the government shutdown entered its fifth week and, on Nov. 4, 2025, became the longest in history, beating a 34-day-plus record set ...

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, ...

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

FDA’s top drug regulator, George Tidmarsh, has resigned following an internal investigation into “serious concerns” about his ...